Product Code: RP-ID-10076442 |
Published Date: 21 Mar 2025 |
Region: Global |
Category: Healthcare & Pharmaceuticals |
Report ID: 10076442
Market Overview:
Research Antibodies Market Analysis by Source (Mouse, Goat, Rabbit, and Other Sources); by Product (Primary, and Secondary Antibodies); by Type (Polyclonal, Monoclonal, and Recombinant Antibodies); and by End User (Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Industry)-Global Supply & Demand Analysis & Opportunity Outlook 2023-2033
Research Antibodies Market Scope Report
|
Base Year |
2022 |
|
Forecast Year |
2023-2033 |
|
CAGR |
~5% |
|
Base Year Market Size (2022) |
~ USD 2.0 Billion |
|
Forecast Year Market Size (2033) |
~ USD XX.X Million |
Global Research Antibodies Market Highlights Over 2023 - 2033
The global research antibodies market is estimated to garner a significant revenue by the end of 2033 by growing at a CAGR of ~X% over the forecast period, i.e., 2023 – 2033. Further, the market generated a revenue of USD 2.0 Billion in the year 2022. The growth of the market can be attributed to the increasing investment by pharmaceutical companies. According to the Congressional Budget Office, pharmaceutical industry has spent nearly USD 83 billion on research and development in 2019, representing 10 times more than what the industry spent in the 1980s in the Unites States.
GET A SAMPLE COPY OF THIS REPORT
Antibodies refer to proteins that are produced by the immune system in order to protect the body when an unwanted substance enters the body. It has uses in various form such as basic research, diagnostic tests, and therapeutics. Moreover, the increase in the population suffering from different kinds of diseases has led to a robust rise in research-based activities in order to develop effective therapy or diagnosis. Therefore, surging chronic diseases are expected to boost the growth of the global research antibodies market. As per the data published by the World Health Organization in 2021, more than 15 million deaths happened from a noncommunicable disease between the ages of 20 and 69 years.
Global Research Antibodies Market: Growth Drivers and Challenges
Growth Drivers
-
Rise in Demand for Neuroscientists – Neuroscientists use research-grade antibodies as basic detection tools, such as a researcher attempting to understand how a cell function has gone wrong can use antibodies to mark and identify specific proteins present within the diseased cell at a specific stage of its life cycle. Hence, it is anticipated to increase the growth of the global research antibodies market. As per the data reported, there has been a rise in the demand for behavioral neuroscientists by 13 per cent in the United States from 2012 to 2022.
-
Growth of Biopharmaceutical Industry– According to the India Brand Equity Foundation, the Indian biotechnology industry is expected to reach USD 150 billion in 2025 from USD 70.2 billion in 2020.
-
Rising Geriatric Population– As per the data reported by World Health Organization, 1 in 6 people around the world will be aged 60 years or above by the end of 2031.
-
Increasing Research & Development Expenditure Across the Globe– According to the World Bank, research and development expenditure has increased from 2.05 per cent of GDP in 2000 to 2.63 per cent of GDP in 2020
Challenges
-
Scarcity of Professionals
-
High Cost for Developing Antibodies
-
Time-Consuming of Identifying Potential Antibodies
The global research antibodies market is segmented and analyzed for demand and supply by source into mouse, goat, rabbit, and other sources. Out of these, the mouse segment is anticipated to hold the largest share over the forecast period owing to their smaller size, and rising reproduction rate. For instance, on an average a female mouse can give birth to 30 to 50 pups every year.
Global Research Antibodies Market Regional Synopsis
Regionally, the global research antibodies market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in the North America region is projected to hold the largest market share by the end of 2033 on the back of a rising number of biopharmaceuticals and biotechnology firms, and growing healthcare infrastructure. For instance, there are more than 2,500 biotechnology businesses in the United States as of 2022.
Market Segmentation
Our in-depth analysis of the global research antibodies market includes the following segments:
|
By Source |
|
|
By Product |
|
|
By Type |
|
|
By End User |
|
Key Companies Dominating the Global Research Antibodies Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global research antibodies market that are included in our report are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Novartis AG, Danaher Corporation, Abcam plc, Becton, Dickinson and Company, Merck KGaA, PerkinElmer Inc., BioLegend, Inc., Cell Signaling Technology, Inc., and others.
Global Research Antibodies Market: Latest Developments
-
October, 2022: Thermo Fisher Scientific Inc., announced the introduction of decentralized clinical trials network for supporting global investigators and research sites for pharmaceutical and biotech customers.
-
March, 2022: Becton, Dickinson and Company announced the introduction of BD Rhapsody assay that allows researchers to more easily and comprehensively analyze important immune system cells, providing a tool to advance research in autoimmune disorders, immuno-oncology, and infectious diseases.
Key Reasons to Buy Our Report
-
The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
-
We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
- Bio-Rad Laboratories Inc.
- Thermo Fisher Scientific Inc.
- Novartis AG
- Danaher Corporation
- Abcam plc
- Becton
- Dickinson and Company
- Merck KGaA
- PerkinElmer Inc.
- BioLegend Inc.
- Cell Signaling Technology Inc.
Related Reports
Proof of Quality & Reliability
